Evidence map›Paper›PMID 26836248›Full record

ArticleExperimental eye research2016

The effect of intravitreal injection of vehicle solutions on form deprivation myopia in tree shrews.

Alexander H Ward, John T Siegwart, Michael R Frost, Thomas T Norton

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Decreased Choroidal Blood Perfusion Induces Myopia in Guinea Pigs.Investigative ophthalmology & visual science · 2021
    Article
  6. Article
  7. Corneal stromal stem cells restore transparency after NStem cells translational medicine · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Juvenile Tree Shrews Do Not Maintain Emmetropia in Narrow-band Blue Light.Optometry and vision science : official publication of the American Academy of Optometry · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexander H WardGenetics, Genomics and Bioinformatics Theme, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: alexward@uab.edu.
John T SiegwartDepartment of Vision Sciences, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Michael R FrostDepartment of Vision Sciences, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Thomas T NortonDepartment of Vision Sciences, School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
University of Alabama at Birmingham · US

Funding

Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
MECHANISMS OF OCULAR DEVELOPMENTR01EY005922 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NORTON, THOMAS T · 1986 to 2012
$4.5M
NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY005922
6 · The paper itself

Abstract

lntravitreal injection of substances dissolved in a vehicle solution is a common tool used to assess retinal function. We examined the effect of injection procedures (three groups) and vehicle solutions (four groups) on the development of form deprivation myopia (FDM) in juvenile tree shrews, mammals closely related to primates, starting at 24 days of visual experience (about 45 days of age). In seven groups (n = 7 per group), the myopia produced by monocular form deprivation (FD) was measured daily for 12 days during an 11-day treatment period. The FD eye was randomly selected; the contralateral eye served as an untreated control. The refractive state of both eyes was measured daily, starting just before FD began (day 1); axial component dimensions were measured on day 1 and after eleven days of treatment (day 12). Procedure groups: the myopia (treated eye - control eye refraction) in the FD group was the reference. The sham group only underwent brief daily anesthesia and opening of the conjunctiva to expose the sclera. The puncture group, in addition, had a pipette inserted daily into the vitreous. In four vehicle groups, 5 μL of vehicle was injected daily. The NaCl group received 0.85% NaCl. In the NaCl + ascorbic acid group, 1 mg/mL of ascorbic acid was added. The water group received sterile water. The water + ascorbic acid group received water with ascorbic acid (1 mg/mL). We found that the procedures associated with intravitreal injections (anesthesia, opening of the conjunctiva, and puncture of the sclera) did not significantly affect the development of FDM. However, injecting 5 μL of any of the four vehicle solutions slowed the development of FDM. NaCl had a small effect; myopia development in the last 6 days (-0.15 ± 0.08 D/day) was significantly less than in the FD group (-0.55 ± 0.06 D/day). NaCl + Ascorbic acid further slowed the development of FDM on several treatment days. H2O (-0.09 ± 0.05 D/day) and H2O + ascorbic acid (-0.08 ± 0.05 D/day) both almost completely blocked myopia development. The treated eye vitreous chamber elongation, compared with the control eye, in all groups was consistent with the amount of myopia. When FD continued (days 12-16) without injections in the water and water + ascorbic acid groups, the rate of myopia development quickly increased. Thus, it appears the vehicles affected retinal signaling rather than causing damage. The effect of water and water + ascorbic acid may be due to reduced osmolality or ionic concentration near the tip of the injection pipette. The effect of ascorbic acid, compared to NaCl alone, may be due to its reported dopaminergic activity.

Indexed as

AnimalsAntioxidantsAscorbic AcidAxial Length, EyeDisease Models, AnimalIntravitreal InjectionsMyopiaOphthalmic SolutionsPharmaceutical VehiclesRefraction, OcularSensory DeprivationSodium ChlorideTupaiidaeAntioxidantsAscorbic AcidOphthalmic SolutionsPharmaceutical VehiclesSodium ChlorideAnimal modelsAxial elongationEmmetropizationMyopiaRetinal signalingVitreous

Identifiers

PMID26836248
PMCPMC4842086
OpenAlexW2270896205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.